Breast cancer patients. Secondary malignant neoplasm of skin
Conditions
Interventions
Intervention 1: Intervention group: Nutrition intervention In the third group, intervention for people participating in the diet study and recommendations to reduce nausea and improve appetite are con
Sponsors
Dezfoul University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Participants must be between 18 and 65 years old. Confirmation of breast cancer diagnosis by pathology and non-metastatic breast cancer. The patient has undergone surgery and then underwent chemotherapy. Informed consent of the patient to accept participation in the study. The consent of the treating oncologist regarding the patient's participation in the present study. The patient does not have an underlying heart disease, does not have a history of previous surgery, and does not have any contraindications for chemotherapy.
Exclusion criteria
Exclusion criteria: Having an underlying heart disease if EF is less than 40. The patient or the treating doctor has requested to withdraw from the study. Have a cognitive disorder. Receive other parallel treatments. The organizers of the plan should diagnose the need to withdraw the patient from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea, vomiting, which score higher in the acute and delayed questionnaire. Timepoint: Before the intervention and after the intervention. Method of measurement: The CINV measurement tool is a standard questionnaire that includes 3 parts: 1. The first part is a predictive nausea and vomiting questionnaire that includes the person's previous experiences of nausea and vomiting before chemotherapy or after chemotherapy. 2. The second part of the tool is related to acute nausea and vomiting, which evaluates the patient's nausea and vomiting during the first 24 hours after chemotherapy and 3. The third part is the questionnaire related to delayed nausea and vomiting, which It examines and evaluates the patient's nausea and vomiting in more than 24 hours since the start of chemotherapy.;Assessing pain with the help of a visual pain scale and obtaining a score higher than 6. Timepoint: Before the intervention and after the intervention. Method of measurement: Visual scale is perhaps one of the most well-known methods forto measure mental phenomena in clinical research. This scaleIn the form of a 10 cm line, a score of zero indicates the absence of painAnd a score of ten is the maximum pain that the patient can imaginewhich was graded horizontally in this study. 2 hours afterCaesarean section, the patient was asked to rate the intensity of his pain by putting a markShow on this line. Obtaining a score of 1-3 indicates mild pain.4-7 is moderate pain and 8-10 is severe pain. Validity and reliability of thisThe tool has been validated in several studies.;Assessing the appetite status using the Short Appetite Status Questionnaire (SNAQ), a score higher than 14 indicates low appetite. Timepoint: Before the intervention and after the intervention. Method of measurement: Short Appetite Status Questionnaire (SNAQ)Due to the sensitive conditions of the patients, the Short Appetite Questionnaire (SNAQ) of the CNAQ questionnaire will be used to evaluate the appetite. This questionnai | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezoo Paliziyan
Dezfoul University of Medical Sciences
Outcome results
None listed